0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Lifestyle and Adiponectin Level: Four-Year Follow-up of Controlled Trials FREE

Katherine Esposito, MD, PhD; Dario Giugliano, MD, PhD
[+] Author Affiliations

Author Affiliations: Department of Geriatrics and Metabolic Diseases, Second University of Naples, Naples, Italy.


Arch Intern Med. 2010;170(14):1270-1271. doi:10.1001/archinternmed.2010.246.
Text Size: A A A
Published online

The adiponectin adipocyte-secreted adipokine has both insulin-enhancer and anti-inflammatory properties1 and is the most consistent biochemical predictor of type 2 diabetes mellitus. Higher adiponectin levels are consistently associated with a lower risk of type 2 diabetes in 13 prospective studies of diverse populations with a total of 14 598 participants and 2623 incident cases of type 2 diabetes, with a relative risk of 0.72 (95% confidence interval, 0.67-0.78) per 1-log μg/mL increment in adiponectin levels.2 Identification of lifestyle changes able to increase adiponectin circulating levels may help refine the strategy against the current diabetes epidemics.

This was a post hoc analysis of randomized controlled trials35 to see whether adiponectin levels were related to success in achieving lifestyle changes. A total of 410 subjects (219 men and 191 women) were originally randomized to an intervention group, based on improvement of quality of diet and increased physical activity, or to a control group (general information about healthy food choices and exercise). The goals of the dietary intervention were a reduction in intake of saturated fat to less than 10% of energy consumed, an increase in intake of monounsaturated fat to 10% or more of energy consumed, and an increase in fiber intake to at least 15 g per 1000 kcal. The goal of physical activity was moderate exercise for at least 30 min/d for at least 5 d/wk. Frequent ingestion of whole-grain products, vegetables, fruits, nuts, low-fat milk, and olive oil was recommended. The subjects also received individual guidance on increasing their level of physical activity: endurance exercise (such as walking, jogging, swimming, aerobic ball games, or skiing) was recommended. The study subjects were ranked according to their success in achieving the goals of the intervention at the 4-year examination. We calculated the percentage of subjects in both groups who had an adiponectin level of 1 μg/mL or more above the median of the sample in each success score category (0, no goal achieved; 1, dietary goal achieved; 2, physical activity goal achieved; and 3, dietary + physical activity goals achieved). Adiponectin levels were assayed with a radioimmunoassay from Linco Research, St Charles, Missouri, which has an intra-assay coefficient of variation of 1.78% to 6.21%.

At baseline, the mean (SD) age of subjects in the intervention and control groups was 41 (6.6) and 41.2 (6.8) years, respectively, and the mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) was 32.4 (5.5) and 32.6 (6.2), respectively. At 4 years, 155 subjects in both groups were still in the program. The median (interquartile range) of plasma adiponectin concentration was 6.1 (3.5-9.1) μg/mL. The Figure shows the numbers of subjects who achieved the goals in each group, as well as the percentage of subjects in each category with adiponectin concentrations of 1 μg/mL or more above the median. The figures were adjusted for weight changes. Absolute numbers of people at goals were significantly lower in the control group; however, percentage values did not show any difference between groups, suggesting that achievement of the goal resulted in raised adiponectin levels independent of the group assignment.

Place holder to copy figure label and caption
Figure.

Subjects achieving adiponectin levels of 1 μg/mL or more above the median at the end of follow-up, according to the success score. *Data are given as number at goal/number not at goal in each category.

Graphic Jump Location

This study provides evidence that circulating adiponectin levels, in the range of those suggested to offer protection from type 2 diabetes, can be obtained by successful lifestyle changes. Our estimate of the effect of the intervention can be considered conservative, since all subjects in the control group also had benefits from the general health advice. The recent results of the long-term Women's Antioxidant Cardiovascular Study,6 which showed no effect from generous doses supplement intake of vitamins A and C and beta carotene on primary prevention of type 2 diabetes, further stress the importance of lifestyle changes for diabetes prevention. Successful lifestyle changes are associated with increased circulating levels of adiponectin in overweight subjects.

Correspondence: Dr Esposito, Department of Geriatrics and Metabolic Diseases, Second University of Naples, Piazza L. Miraglia, 80138 Naples, Italy (katherine.esposito@unina2.it).

Author Contributions:Study concept and design: Esposito and Giugliano. Acquisition of data: Esposito and Giugliano. Drafting of the manuscript: Esposito and Giugliano. Critical revision of the manuscript for important intellectual content: Esposito and Giugliano. Statistical analysis: Giugliano. Administrative, technical, and material support: Esposito. Study supervision: Esposito and Giugliano.

Financial Disclosure: None reported.

Funding/Support: This work was supported in part by a grant from the Second University of Naples, Naples, Italy.

Kadowaki  TYamauchi  TKubota  NHara  KUeki  KTobe  K Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116 (7) 1784- 1792
PubMed Link to Article
Li  SShin  HJDing  ELvan Dam  RM Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009;302 (2) 179- 188
PubMed Link to Article
Esposito  KPontillo  ADi Palo  C  et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289 (14) 1799- 1804
PubMed Link to Article
Esposito  KGiugliano  FDi Palo  C  et al.  Effects of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004;291 (24) 2978- 2984
PubMed Link to Article
Esposito  KMarfella  RCiotola  M  et al.  Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292 (12) 1440- 1446
PubMed Link to Article
Song  YCook  NRAlbert  CMVan Denburgh  MManson  JE Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am J Clin Nutr 2009;90 (2) 429- 437
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure.

Subjects achieving adiponectin levels of 1 μg/mL or more above the median at the end of follow-up, according to the success score. *Data are given as number at goal/number not at goal in each category.

Graphic Jump Location

Tables

References

Kadowaki  TYamauchi  TKubota  NHara  KUeki  KTobe  K Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116 (7) 1784- 1792
PubMed Link to Article
Li  SShin  HJDing  ELvan Dam  RM Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009;302 (2) 179- 188
PubMed Link to Article
Esposito  KPontillo  ADi Palo  C  et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289 (14) 1799- 1804
PubMed Link to Article
Esposito  KGiugliano  FDi Palo  C  et al.  Effects of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004;291 (24) 2978- 2984
PubMed Link to Article
Esposito  KMarfella  RCiotola  M  et al.  Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292 (12) 1440- 1446
PubMed Link to Article
Song  YCook  NRAlbert  CMVan Denburgh  MManson  JE Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am J Clin Nutr 2009;90 (2) 429- 437
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 4

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles